Soluble Guanylate Cyclase Stimulator [EPC]

Soluble Guanylate Cyclase Stimulator [EPC] was reported 33867 times

Drugs of the Soluble Guanylate Cyclase Stimulator [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PULMONARY ANGIOPLASTY 23 0.8214
1 PULMONARY ENDARTERECTOMY 90 0.6164
2 PULMONARY ARTERY THERAPEUTIC PROCEDURE 20 0.5000
3 ENDARTERECTOMY 57 0.2545
4 BENDOPNOEA 42 0.1909
5 DIASTOLIC HYPOTENSION 32 0.1893
6 DIURETIC THERAPY 13 0.1806
7 PULMONARY ARTERY OCCLUSION 16 0.1667
8 DIALYSIS HYPOTENSION 14 0.1414
9 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 24 0.1379
10 WALKING DISTANCE TEST ABNORMAL 53 0.1355
11 TRANSPLANT EVALUATION 67 0.1319
12 DEVICE WIRELESS COMMUNICATION ISSUE 32 0.1236
13 CATHETER SITE VESICLES 24 0.1231
14 PULMONARY ARTERIAL PRESSURE INCREASED 179 0.1098
15 CATHETER MANAGEMENT 98 0.1090
16 DEVICE MAINTENANCE ISSUE 64 0.1088
17 CATHETER SITE PRURITUS 90 0.1025
18 CARDIAC OUTPUT INCREASED 16 0.0936
19 CARDIAC FAILURE HIGH OUTPUT 22 0.0913
20 CATHETER SITE RASH 37 0.0819
21 THROMBECTOMY 26 0.0805
22 PULMONARY ARTERIAL HYPERTENSION 1130 0.0779
23 VASCULAR DEVICE OCCLUSION 26 0.0767
24 PULMONARY ARTERIAL PRESSURE ABNORMAL 22 0.0764
25 OXYGEN CONSUMPTION INCREASED 180 0.0753
26 CATHETER SITE IRRITATION 25 0.0751
27 INFUSION SITE INFECTION 171 0.0735
28 RIGHT VENTRICULAR FAILURE 498 0.0710
29 DIZZINESS EXERTIONAL 52 0.0684
30 PARACENTESIS 41 0.0667
31 CATHETER SITE ERYTHEMA 142 0.0663
32 CATHETER SITE DISCHARGE 72 0.0641
33 INFUSION SITE WARMTH 76 0.0620
34 INFUSION SITE ABSCESS 30 0.0595
35 OXYGEN SUPPLEMENTATION 44 0.0595
36 CATHETERISATION CARDIAC ABNORMAL 16 0.0593
37 DEPENDENCE ON OXYGEN THERAPY 29 0.0588
38 OXYGEN THERAPY 96 0.0584
39 INFUSION SITE DISCHARGE 102 0.0581
40 MINERAL SUPPLEMENTATION 26 0.0580
41 INFUSION SITE INDURATION 85 0.0573
42 INFUSION SITE INFLAMMATION 40 0.0567
43 CATHETER SITE SWELLING 51 0.0545
44 INFUSION SITE PAIN 687 0.0533
45 RIGHT VENTRICULAR ENLARGEMENT 17 0.0531
46 PULMONARY VENO-OCCLUSIVE DISEASE 37 0.0529
47 BLOOD PRESSURE SYSTOLIC DECREASED 237 0.0521
48 RIGHT VENTRICULAR DILATATION 30 0.0518
49 INFUSION SITE IRRITATION 66 0.0514
50 INFUSION SITE VESICLES 27 0.0513
51 DYSPNOEA AT REST 143 0.0493
52 CATHETERISATION CARDIAC 218 0.0491
53 INFUSION SITE HAEMORRHAGE 158 0.0480
54 INFUSION SITE CELLULITIS 25 0.0473
55 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 15 0.0473
56 INFUSION SITE ERYTHEMA 385 0.0456
57 PULMONARY HYPERTENSION 937 0.0449
58 DEVICE INFUSION ISSUE 111 0.0447
59 CATHETER SITE PAIN 116 0.0447
60 DYSPNOEA EXERTIONAL 1585 0.0420
61 LUNG TRANSPLANT 148 0.0418
62 ANGIOPLASTY 62 0.0415
63 INFUSION SITE DISCOMFORT 43 0.0415
64 HYPERVOLAEMIA 204 0.0412
65 DEVICE ALARM ISSUE 74 0.0407
66 CATHETER SITE EXTRAVASATION 16 0.0401
67 VASCULAR DEVICE INFECTION 180 0.0396
68 PAIN IN JAW 1092 0.0385
69 CATHETER SITE HAEMORRHAGE 96 0.0383
70 ABDOMINAL CAVITY DRAINAGE 16 0.0379
71 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 21 0.0374
72 SICKLE CELL DISEASE 17 0.0368
73 RIGHT VENTRICULAR DYSFUNCTION 40 0.0363
74 CHRONIC LEFT VENTRICULAR FAILURE 13 0.0361
75 INFUSION SITE SWELLING 227 0.0360
76 SICKLE CELL ANAEMIA 23 0.0357
77 FLUID RETENTION 1775 0.0349
78 CATHETER SITE RELATED REACTION 26 0.0347
79 INFUSION SITE RASH 47 0.0342
80 CATHETER SITE INFLAMMATION 19 0.0337
81 BRAIN NATRIURETIC PEPTIDE INCREASED 102 0.0331
82 BLOOD PRESSURE DIASTOLIC DECREASED 239 0.0323
83 LUNG OPERATION 27 0.0322
84 JUGULAR VEIN DISTENSION 18 0.0317
85 MEDICAL PROCEDURE 51 0.0306
86 INFUSION SITE PRURITUS 96 0.0304
87 FLUID OVERLOAD 436 0.0299
88 CENTRAL VENOUS CATHETER REMOVAL 14 0.0299
89 DIZZINESS POSTURAL 289 0.0298
90 CARDIORENAL SYNDROME 17 0.0297
91 CENTRAL VENOUS CATHETERISATION 89 0.0295
92 COR PULMONALE 28 0.0293
93 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 39 0.0278
94 LOCALISED OEDEMA 128 0.0276
95 INFUSION SITE DISCOLOURATION 24 0.0273
96 TRANSFUSION 280 0.0267
97 PACKED RED BLOOD CELL TRANSFUSION 34 0.0257
98 CHRONIC RESPIRATORY FAILURE 31 0.0257
99 INFUSION SITE REACTION 76 0.0254
100 ASPIRATION PLEURAL CAVITY 19 0.0247
101 INTRA-ABDOMINAL FLUID COLLECTION 44 0.0245
102 SCLERODERMA 89 0.0245
103 TRAUMATIC FRACTURE 18 0.0245
104 INFUSION SITE URTICARIA 16 0.0239
105 SYSTEMIC SCLERODERMA 17 0.0234
106 INFUSION SITE OEDEMA 19 0.0227
107 NOCTURNAL DYSPNOEA 29 0.0227
108 OXYGEN SATURATION DECREASED 1274 0.0226
109 CATHETER PLACEMENT 42 0.0226
110 FOOD REFUSAL 18 0.0206
111 RALES 118 0.0203
112 PULMONARY PAIN 58 0.0198
113 INFUSION SITE NODULE 19 0.0198
114 OEDEMA 1072 0.0197
115 CATHETER SITE INFECTION 74 0.0195
116 SEASONAL ALLERGY 276 0.0195
117 CARDIAC SEPTAL DEFECT 14 0.0195
118 OXYGEN SATURATION ABNORMAL 55 0.0194
119 HAEMOPTYSIS 540 0.0193
120 EMERGENCY CARE 58 0.0191
121 CRITICAL ILLNESS 14 0.0179
122 HYPOTENSION 3564 0.0177
123 INTENSIVE CARE 25 0.0176
124 DEVICE CONNECTION ISSUE 37 0.0175
125 DRUG DOSE TITRATION NOT PERFORMED 32 0.0175
126 CARDIAC ABLATION 31 0.0173
127 CARDIOVERSION 24 0.0172
128 DERMATITIS CONTACT 195 0.0171
129 CARDIAC OUTPUT DECREASED 15 0.0170
130 ARTERIOVENOUS MALFORMATION 15 0.0165
131 PULMONARY THROMBOSIS 180 0.0165
132 PROCEDURAL HYPOTENSION 14 0.0165
133 THERAPY CHANGE 159 0.0162
134 CARBON DIOXIDE INCREASED 22 0.0161
135 ECHOCARDIOGRAM ABNORMAL 22 0.0157
136 REHABILITATION THERAPY 60 0.0155
137 EXERCISE TOLERANCE DECREASED 88 0.0153
138 HOSPITALISATION 2346 0.0153
139 OEDEMA PERIPHERAL 1819 0.0149
140 NASAL CONGESTION 850 0.0144
141 BLOOD PRESSURE DECREASED 932 0.0140
142 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 14 0.0139
143 INFUSION SITE MASS 15 0.0138
144 DEVICE POWER SOURCE ISSUE 40 0.0137
145 INJECTION SITE INFECTION 45 0.0137
146 DRUG TITRATION ERROR 35 0.0135
147 BLADDER CATHETERISATION 13 0.0134
148 PERICARDIAL EFFUSION 308 0.0133
149 HYPOXIA 469 0.0133
150 DEVICE RELATED INFECTION 200 0.0130
151 HAEMOGLOBIN INCREASED 59 0.0129
152 DEVICE RELATED SEPSIS 26 0.0129
153 DYSPEPSIA 1268 0.0129
154 LEFT VENTRICULAR FAILURE 44 0.0128
155 VASODILATATION 32 0.0127
156 ACUTE RESPIRATORY FAILURE 244 0.0127
157 LABILE BLOOD PRESSURE 15 0.0126
158 INFUSION SITE BRUISING 27 0.0125
159 CARDIAC FAILURE ACUTE 82 0.0123
160 COLONOSCOPY 27 0.0122
161 INTERNAL HAEMORRHAGE 140 0.0122
162 EJECTION FRACTION ABNORMAL 15 0.0122
163 BREATH SOUNDS ABNORMAL 60 0.0122
164 EPISTAXIS 902 0.0120
165 BLOOD PRESSURE ABNORMAL 238 0.0120
166 BLOOD LOSS ANAEMIA 27 0.0119
167 CARDIAC FAILURE CHRONIC 50 0.0117
168 MIDDLE EAR EFFUSION 25 0.0113
169 NASAL DRYNESS 71 0.0113
170 ORTHOPNOEA 36 0.0113
171 PRESYNCOPE 274 0.0113
172 BLOOD ELECTROLYTES DECREASED 16 0.0113
173 ASCITES 330 0.0112
174 ATRIAL FLUTTER 89 0.0111
175 CONCOMITANT DISEASE AGGRAVATED 68 0.0110
176 PERIPHERAL SWELLING 1677 0.0109
177 SYNCOPE 1075 0.0107
178 DISEASE COMPLICATION 49 0.0107
179 DRUG TOLERANCE DECREASED 30 0.0107
180 LOWER RESPIRATORY TRACT CONGESTION 18 0.0106
181 SINUS CONGESTION 142 0.0105
182 GENERALISED OEDEMA 130 0.0105
183 WEIGHT ABNORMAL 25 0.0104
184 DECREASED ACTIVITY 112 0.0104
185 DYSPNOEA 5830 0.0103
186 PRODUCTIVE COUGH 488 0.0102
187 DIALYSIS 145 0.0102
188 DEVICE OCCLUSION 142 0.0101
189 CARDIAC DISCOMFORT 20 0.0099
190 LIP INJURY 13 0.0099
191 PURULENT DISCHARGE 42 0.0098
192 BLOOD POTASSIUM DECREASED 293 0.0097
193 PARANASAL SINUS HYPERSECRETION 37 0.0097
194 COMPLICATION ASSOCIATED WITH DEVICE 140 0.0096
195 HAEMORRHOIDAL HAEMORRHAGE 47 0.0096
196 MULTIPLE ALLERGIES 75 0.0096
197 PAINFUL RESPIRATION 23 0.0095
198 BLOOD IRON DECREASED 113 0.0095
199 WRONG DOSE 23 0.0095
200 MECHANICAL VENTILATION 18 0.0095
201 HOSPICE CARE 93 0.0094
202 RESPIRATORY TRACT CONGESTION 149 0.0094
203 ENDOTRACHEAL INTUBATION 26 0.0093
204 GASTROOESOPHAGEAL REFLUX DISEASE 742 0.0092
205 FAECES SOFT 67 0.0092
206 IRON DEFICIENCY ANAEMIA 85 0.0092
207 GASTRIC DILATATION 15 0.0090
208 THERAPY NON-RESPONDER 389 0.0086
209 OTORRHOEA 15 0.0086
210 HERNIA REPAIR 22 0.0085
211 RESPIRATION ABNORMAL 58 0.0084
212 MYOCARDIAL NECROSIS MARKER INCREASED 14 0.0083
213 SPUTUM DISCOLOURED 78 0.0082
214 WEIGHT FLUCTUATION 86 0.0082
215 RESPIRATORY TRACT INFECTION VIRAL 19 0.0082
216 EAR CONGESTION 22 0.0081
217 PULMONARY OEDEMA 363 0.0081
218 GOUT 145 0.0081
219 CARDIAC OPERATION 69 0.0080
220 PRODUCT ADMINISTRATION INTERRUPTED 63 0.0080
221 ABDOMINAL DISTENSION 837 0.0080
222 NASAL OBSTRUCTION 15 0.0080
223 THROMBOSIS IN DEVICE 26 0.0079
224 TERMINAL STATE 53 0.0079
225 CARDIAC PACEMAKER INSERTION 47 0.0079
226 CHOKING SENSATION 43 0.0078
227 ABNORMAL LOSS OF WEIGHT 53 0.0078
228 PULMONARY CONGESTION 102 0.0077
229 PRODUCT SUPPLY ISSUE 55 0.0077
230 RETCHING 164 0.0077
231 CONCOMITANT DISEASE PROGRESSION 15 0.0077
232 FACE INJURY 29 0.0076
233 CARDIAC FAILURE 605 0.0075
234 LUNG DISORDER 369 0.0075
235 CHEST PAIN 1383 0.0075
236 FLUSHING 756 0.0074
237 PANCREATIC CYST 14 0.0073
238 DIZZINESS 3654 0.0073
239 HEADACHE 4590 0.0073
240 SINUS PAIN 17 0.0073
241 FOOD POISONING 39 0.0073
242 EYE CONTUSION 15 0.0071
243 GASTRIC POLYPS 16 0.0071
244 SINUS DISORDER 140 0.0071
245 SMALL INTESTINAL OBSTRUCTION 86 0.0070
246 PALPITATIONS 813 0.0069
247 HYPOPNOEA 24 0.0069
248 PARANASAL SINUS DISCOMFORT 26 0.0069
249 HEART RATE ABNORMAL 38 0.0068
250 INVESTIGATION 21 0.0067
251 HEAD INJURY 211 0.0067
252 ATRIAL TACHYCARDIA 14 0.0067
253 OCCULT BLOOD POSITIVE 13 0.0066
254 CARDIOMEGALY 81 0.0066
255 UPPER RESPIRATORY TRACT CONGESTION 19 0.0066
256 COUGH 1838 0.0065
257 GASTRIC INFECTION 25 0.0065
258 PULMONARY HAEMORRHAGE 51 0.0065
259 CARDIAC FLUTTER 42 0.0065
260 SUFFOCATION FEELING 16 0.0064
261 EAR DISCOMFORT 66 0.0064
262 RHINOVIRUS INFECTION 25 0.0064
263 DISCOURAGEMENT 15 0.0064
264 DEATH 5519 0.0064
265 CHEST DISCOMFORT 654 0.0064
266 HEAD DISCOMFORT 113 0.0064
267 SKIN ABRASION 30 0.0063
268 HAEMATEMESIS 160 0.0063
269 BLOOD COUNT ABNORMAL 95 0.0063
270 PULMONARY ALVEOLAR HAEMORRHAGE 35 0.0062
271 CARDIAC FAILURE CONGESTIVE 497 0.0062
272 CARDIAC DYSFUNCTION 23 0.0062
273 SWELLING 577 0.0062
274 HAEMATOCRIT INCREASED 14 0.0061
275 THROAT IRRITATION 275 0.0061
276 FACIAL BONES FRACTURE 22 0.0061
277 HEART RATE INCREASED 605 0.0061
278 VIRAL UPPER RESPIRATORY TRACT INFECTION 29 0.0061
279 DEVICE FAILURE 92 0.0060
280 GASTROENTERITIS VIRAL 109 0.0060
281 GASTRIC DISORDER 204 0.0059
282 TRANSPLANT 14 0.0059
283 UPPER-AIRWAY COUGH SYNDROME 48 0.0058
284 INTERNATIONAL NORMALISED RATIO ABNORMAL 20 0.0058
285 CLOSTRIDIUM DIFFICILE INFECTION 123 0.0056
286 EPIGASTRIC DISCOMFORT 22 0.0056
287 BLOOD POTASSIUM ABNORMAL 15 0.0056
288 POLYURIA 46 0.0056
289 ABDOMINAL DISCOMFORT 941 0.0056
290 DIARRHOEA 3598 0.0056
291 PNEUMONIA 1790 0.0055
292 HAEMORRHAGE URINARY TRACT 14 0.0055
293 LIVER TRANSPLANT 20 0.0055
294 BLOOD PRESSURE FLUCTUATION 131 0.0055
295 HAEMOGLOBIN DECREASED 558 0.0054
296 INJECTION SITE DISCHARGE 29 0.0054
297 GASTROENTERITIS 78 0.0053
298 HAEMORRHAGIC DIATHESIS 19 0.0053
299 IRON DEFICIENCY 24 0.0053
300 SUPRAVENTRICULAR TACHYCARDIA 51 0.0053
301 LUNG OPACITY 14 0.0053
302 HYPERCAPNIA 16 0.0053
303 DEVICE DISLOCATION 230 0.0053
304 RESPIRATORY FAILURE 379 0.0052
305 ABDOMINAL RIGIDITY 14 0.0052
306 DECREASED APPETITE 1193 0.0051
307 LOSS OF CONSCIOUSNESS 658 0.0051
308 FEEDING DISORDER 104 0.0051
309 MOUTH HAEMORRHAGE 37 0.0050
310 URINE OUTPUT DECREASED 44 0.0050
311 INCREASED TENDENCY TO BRUISE 46 0.0050
312 UNEVALUABLE EVENT 378 0.0050
313 PLEURAL EFFUSION 304 0.0050
314 CELLULITIS 249 0.0049
315 JOINT SWELLING 596 0.0049
316 TRICUSPID VALVE INCOMPETENCE 39 0.0049
317 DEAFNESS UNILATERAL 27 0.0049
318 ANIMAL BITE 13 0.0049
319 BLOOD MAGNESIUM DECREASED 42 0.0049
320 NAUSEA 3850 0.0049
321 GASTROINTESTINAL MOTILITY DISORDER 26 0.0049
322 GASTROINTESTINAL DISORDER 435 0.0049
323 INCORRECT PRODUCT ADMINISTRATION DURATION 105 0.0048
324 PRODUCT LEAKAGE 27 0.0048
325 SLUGGISHNESS 49 0.0048
326 RESPIRATORY SYNCYTIAL VIRUS INFECTION 41 0.0047
327 GASTROINTESTINAL HAEMORRHAGE 393 0.0047
328 GALLBLADDER OPERATION 19 0.0047
329 GASTRIC HAEMORRHAGE 54 0.0047
330 OESOPHAGEAL ULCER 18 0.0047
331 FAECES HARD 18 0.0046
332 VOMITING 2161 0.0046
333 ORTHOSTATIC HYPOTENSION 80 0.0046
334 PROCEDURAL COMPLICATION 35 0.0046
335 INTERNATIONAL NORMALISED RATIO INCREASED 130 0.0046
336 OESOPHAGEAL PAIN 18 0.0046
337 PAIN IN EXTREMITY 1337 0.0045
338 WEIGHT INCREASED 1011 0.0045
339 ERUCTATION 87 0.0045
340 CHEMOTHERAPY 17 0.0045
341 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 234 0.0045
342 BLOOD BLISTER 14 0.0045
343 FAECES DISCOLOURED 97 0.0045
344 RESPIRATORY DISTRESS 123 0.0045
345 CONSTIPATION 969 0.0044
346 RENAL DISORDER 207 0.0044
347 PNEUMONIA VIRAL 14 0.0044
348 SECRETION DISCHARGE 55 0.0044
349 FLATULENCE 249 0.0044
350 SINUS HEADACHE 26 0.0044
351 CREPITATIONS 13 0.0044
352 CARDIOPULMONARY FAILURE 17 0.0044
353 INTESTINAL OBSTRUCTION 164 0.0043
354 OLIGURIA 27 0.0043
355 CERVICAL VERTEBRAL FRACTURE 15 0.0043
356 ATRIAL FIBRILLATION 423 0.0043
357 LYMPHOEDEMA 30 0.0043
358 WEIGHT DECREASED 1211 0.0043
359 NASOPHARYNGITIS 798 0.0043
360 OROPHARYNGEAL DISCOMFORT 39 0.0043
361 ABDOMINAL PAIN UPPER 887 0.0043
362 AORTIC STENOSIS 15 0.0043
363 ANAEMIA 820 0.0043
364 CARDIOGENIC SHOCK 61 0.0042
365 PERIORBITAL SWELLING 24 0.0042
366 RECTAL HAEMORRHAGE 182 0.0042
367 DEHYDRATION 565 0.0042
368 LIMB INJURY 115 0.0042
369 CATARACT OPERATION 25 0.0042
370 DIASTOLIC DYSFUNCTION 13 0.0042
371 DEVICE PLACEMENT ISSUE 15 0.0042
372 SICKLE CELL ANAEMIA WITH CRISIS 66 0.0042
373 PERIPHERAL VENOUS DISEASE 17 0.0042
374 NASAL DISCOMFORT 33 0.0042
375 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 14 0.0042
376 PRODUCT AVAILABILITY ISSUE 94 0.0041
377 INFLUENZA 460 0.0041
378 AMMONIA INCREASED 21 0.0041
379 HAEMATOCHEZIA 226 0.0041
380 MUSCULOSKELETAL CHEST PAIN 63 0.0041
381 FLANK PAIN 38 0.0040
382 BLOOD PRESSURE SYSTOLIC INCREASED 79 0.0040
383 HAEMORRHOIDS 79 0.0040
384 CHOKING 79 0.0040
385 SENSITIVITY TO WEATHER CHANGE 21 0.0040
386 FEELING ABNORMAL 956 0.0040
387 FEELING COLD 111 0.0040
388 STENT PLACEMENT 32 0.0040
389 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 35 0.0040
390 BEDRIDDEN 52 0.0040
391 RHINORRHOEA 255 0.0039
392 MALAISE 1722 0.0039
393 FATIGUE 3054 0.0039
394 PRODUCT PRESCRIBING ISSUE 85 0.0039
395 INCORRECT DOSAGE ADMINISTERED 19 0.0039
396 SKIN LACERATION 42 0.0039
397 MELAENA 85 0.0039
398 BLOOD SODIUM DECREASED 72 0.0038
399 MUSCLE STRAIN 33 0.0038
400 UPPER RESPIRATORY TRACT INFECTION 176 0.0038
401 ABNORMAL WEIGHT GAIN 47 0.0038
402 GASTRITIS 100 0.0038
403 ASPHYXIA 31 0.0038
404 ASTHENIA 1425 0.0038
405 CARDIAC TAMPONADE 18 0.0038
406 HEPATIC CIRRHOSIS 71 0.0038
407 PRODUCT DOSE OMISSION 246 0.0038
408 HEART RATE IRREGULAR 85 0.0038
409 LARGE INTESTINE POLYP 26 0.0037
410 GINGIVAL BLEEDING 51 0.0037
411 LOCALISED INFECTION 90 0.0037
412 EAR DISORDER 17 0.0037
413 FALL 1234 0.0037
414 HIATUS HERNIA 48 0.0037
415 NECK PAIN 206 0.0037
416 RESPIRATORY TRACT INFECTION 96 0.0037
417 VARICOSE VEIN 19 0.0037
418 SLEEP APNOEA SYNDROME 70 0.0037
419 HAEMORRHAGE SUBCUTANEOUS 13 0.0037
420 THYROID MASS 14 0.0036
421 GALLBLADDER DISORDER 65 0.0036
422 OROPHARYNGEAL PAIN 336 0.0036
423 BRONCHITIS 268 0.0036
424 HAEMORRHAGE 373 0.0036
425 ULCER HAEMORRHAGE 24 0.0035
426 HAEMODYNAMIC INSTABILITY 27 0.0035
427 MUSCLE FATIGUE 15 0.0035
428 INCORRECT DRUG ADMINISTRATION RATE 15 0.0035
429 ABDOMINAL HERNIA 16 0.0035
430 CARDIAC VALVE DISEASE 20 0.0035
431 BLOOD DISORDER 28 0.0035
432 MYALGIA 593 0.0035
433 HYSTERECTOMY 30 0.0035
434 DRUG INTOLERANCE 334 0.0035
435 ILLNESS 356 0.0035
436 POOR QUALITY SLEEP 74 0.0034
437 HYPERSOMNIA 98 0.0034
438 CONJUNCTIVAL HAEMORRHAGE 13 0.0034
439 THERAPY PARTIAL RESPONDER 53 0.0034
440 ASPIRATION 37 0.0034
441 CARDIAC DISORDER 316 0.0034
442 TOOTH EXTRACTION 42 0.0034
443 INFUSION SITE EXTRAVASATION 21 0.0034
444 CYANOSIS 53 0.0034
445 HEART RATE DECREASED 118 0.0034
446 COMPRESSION FRACTURE 18 0.0034
447 HEPATOMEGALY 33 0.0034
448 PULSELESS ELECTRICAL ACTIVITY 14 0.0033
449 DRY THROAT 34 0.0033
450 SNEEZING 75 0.0033
451 ATRIAL SEPTAL DEFECT 28 0.0033
452 LIGAMENT SPRAIN 33 0.0033
453 COVID-19 PNEUMONIA 39 0.0033
454 IMPAIRED GASTRIC EMPTYING 45 0.0033
455 DEVICE PHYSICAL PROPERTY ISSUE 25 0.0033
456 MIGRAINE 311 0.0033
457 THROMBOSIS 262 0.0033
458 EYE OPERATION 15 0.0033
459 THERAPY CESSATION 167 0.0032
460 MUSCULOSKELETAL PAIN 170 0.0032
461 HAEMATOCRIT DECREASED 64 0.0032
462 WHEEZING 191 0.0032
463 DIVERTICULITIS 89 0.0032
464 DIARRHOEA HAEMORRHAGIC 30 0.0032
465 DEVICE LEAKAGE 139 0.0032
466 OESOPHAGITIS 35 0.0032
467 FACE OEDEMA 54 0.0032
468 ACCIDENT 38 0.0032
469 POST PROCEDURAL HAEMORRHAGE 37 0.0032
470 HYPERTHYROIDISM 46 0.0032
471 NEURALGIA 77 0.0032
472 TREATMENT NONCOMPLIANCE 173 0.0032
473 PNEUMONIA BACTERIAL 29 0.0032
474 GAIT INABILITY 105 0.0031
475 VIRAL INFECTION 104 0.0031
476 ENDOCARDITIS 16 0.0031
477 LETHARGY 179 0.0031
478 ATELECTASIS 30 0.0031
479 SEPSIS 345 0.0031
480 UPPER GASTROINTESTINAL HAEMORRHAGE 52 0.0031
481 EAR PAIN 60 0.0031
482 SENSATION OF FOREIGN BODY 26 0.0031
483 BLOOD URINE PRESENT 58 0.0031
484 HERNIA 59 0.0030
485 EAR INFECTION 81 0.0030
486 GASTROINTESTINAL SOUNDS ABNORMAL 15 0.0030
487 BACK PAIN 701 0.0030
488 RENAL FUNCTION TEST ABNORMAL 14 0.0030
489 OCULAR ICTERUS 13 0.0030
490 EYE HAEMORRHAGE 40 0.0030
491 LIMB DISCOMFORT 92 0.0030
492 INGUINAL HERNIA 18 0.0030
493 EATING DISORDER 63 0.0030
494 BACTERAEMIA 35 0.0029
495 TACHYCARDIA 261 0.0029
496 SUBDURAL HAEMATOMA 42 0.0029
497 BLOOD TEST ABNORMAL 41 0.0029
498 PNEUMOTHORAX 46 0.0029
499 URINARY TRACT INFECTION 492 0.0029
500 ENERGY INCREASED 17 0.0029
501 CORONAVIRUS INFECTION 19 0.0029
502 POST PROCEDURAL COMPLICATION 55 0.0029
503 UNINTENTIONAL MEDICAL DEVICE REMOVAL 33 0.0028
504 ARRHYTHMIA 135 0.0028
505 BACK INJURY 31 0.0028
506 SYSTEMIC LUPUS ERYTHEMATOSUS 101 0.0028
507 ELECTROLYTE IMBALANCE 33 0.0028
508 MUSCLE TIGHTNESS 46 0.0028
509 WRIST FRACTURE 34 0.0028
510 CONTUSION 273 0.0028
511 LUNG INFECTION 44 0.0028
512 SURGERY 166 0.0028
513 GENERAL PHYSICAL HEALTH DETERIORATION 327 0.0028
514 SWELLING FACE 184 0.0028
515 RIB FRACTURE 58 0.0028
516 ABDOMINAL TENDERNESS 14 0.0028
517 CHOLECYSTECTOMY 32 0.0028
518 FLUID INTAKE REDUCED 14 0.0028
519 SINUSITIS 286 0.0028
520 MUSCULOSKELETAL DISCOMFORT 48 0.0028
521 COLD SWEAT 49 0.0028
522 ANAL INCONTINENCE 25 0.0028
523 FREQUENT BOWEL MOVEMENTS 75 0.0028
524 MENTAL STATUS CHANGES 77 0.0028
525 TOOTHACHE 50 0.0028
526 HAEMATOMA 71 0.0027
527 UTERINE LEIOMYOMA 20 0.0027
528 CLOSTRIDIUM DIFFICILE COLITIS 29 0.0027
529 HYPOVOLAEMIA 16 0.0027
530 BACTERIAL INFECTION 51 0.0027
531 CONCUSSION 21 0.0027
532 LOWER GASTROINTESTINAL HAEMORRHAGE 20 0.0027
533 RESPIRATORY RATE INCREASED 24 0.0027
534 INTENTIONAL DOSE OMISSION 77 0.0027
535 SCIATICA 43 0.0027
536 FAILURE TO THRIVE 14 0.0027
537 ABDOMINAL PAIN 627 0.0027
538 PHOTOPSIA 17 0.0027
539 HAND FRACTURE 19 0.0027
540 GASTROINTESTINAL INFECTION 24 0.0027
541 RESPIRATORY DISORDER 80 0.0027
542 PULMONARY EMBOLISM 253 0.0027
543 POLLAKIURIA 111 0.0027
544 TOOTH ABSCESS 27 0.0026
545 BLOOD POTASSIUM INCREASED 43 0.0026
546 CHOLECYSTITIS ACUTE 15 0.0026
547 LABORATORY TEST ABNORMAL 78 0.0026
548 GASTROINTESTINAL PAIN 29 0.0026
549 MUCOUS STOOLS 13 0.0026
550 JOINT INJURY 56 0.0026
551 TINNITUS 120 0.0026
552 POLYP 17 0.0026
553 PRODUCT DISTRIBUTION ISSUE 24 0.0026
554 ANKLE FRACTURE 40 0.0026
555 SKIN WARM 15 0.0026
556 LACERATION 24 0.0025
557 ASTHENOPIA 14 0.0025
558 PALLOR 69 0.0025
559 RESTLESS LEGS SYNDROME 46 0.0025
560 SEPTIC SHOCK 110 0.0025
561 HYPOPHAGIA 64 0.0025
562 HAEMOGLOBIN ABNORMAL 16 0.0025
563 CANDIDA INFECTION 42 0.0025
564 THYROID DISORDER 38 0.0025
565 TASTE DISORDER 50 0.0025
566 DECUBITUS ULCER 20 0.0025
567 KIDNEY INFECTION 48 0.0024
568 HIP FRACTURE 78 0.0024
569 CONDITION AGGRAVATED 734 0.0024
570 MALNUTRITION 27 0.0024
571 RENAL IMPAIRMENT 201 0.0024
572 FEELING OF BODY TEMPERATURE CHANGE 14 0.0024
573 CHILLS 276 0.0024
574 HEAVY MENSTRUAL BLEEDING 21 0.0023
575 ILEUS 29 0.0023
576 RENAL FAILURE 309 0.0023
577 LIVER DISORDER 103 0.0023
578 FEELING JITTERY 44 0.0023
579 MUSCLE SPASMS 423 0.0023
580 SPLENOMEGALY 27 0.0023
581 THERAPY INTERRUPTED 164 0.0023
582 DYSPHONIA 134 0.0023
583 PLATELET COUNT DECREASED 244 0.0023
584 EMPHYSEMA 23 0.0023
585 NERVE COMPRESSION 21 0.0023
586 SCRATCH 24 0.0023
587 RED BLOOD CELL COUNT DECREASED 65 0.0023
588 SARS-COV-2 TEST POSITIVE 30 0.0023
589 BLOOD UREA INCREASED 38 0.0023
590 FULL BLOOD COUNT ABNORMAL 24 0.0023
591 ADVERSE EVENT 209 0.0023
592 FEELING HOT 139 0.0023
593 VERTIGO 138 0.0023
594 APPETITE DISORDER 15 0.0023
595 GASTRIC ULCER 43 0.0023
596 PRODUCT DOSE OMISSION ISSUE 664 0.0023
597 ENTEROCOLITIS 13 0.0022
598 STAPHYLOCOCCAL INFECTION 74 0.0022
599 ARTHRALGIA 932 0.0022
600 FACIAL PAIN 20 0.0022
601 LEFT VENTRICULAR DYSFUNCTION 15 0.0022
602 INFLUENZA LIKE ILLNESS 184 0.0022
603 TROPONIN INCREASED 17 0.0022
604 RHINITIS 18 0.0022
605 HOT FLUSH 168 0.0022
606 FRUSTRATION TOLERANCE DECREASED 18 0.0022
607 NERVOUSNESS 116 0.0022
608 COLON CANCER 33 0.0022
609 UPPER LIMB FRACTURE 44 0.0022
610 EYE SWELLING 82 0.0022
611 SPINAL OPERATION 27 0.0022
612 PULMONARY FIBROSIS 42 0.0022
613 PERIPHERAL COLDNESS 30 0.0022
614 DRUG DOSE OMISSION 361 0.0022
615 PROTHROMBIN TIME PROLONGED 13 0.0022
616 SKIN ULCER 56 0.0022
617 INJECTION SITE INDURATION 28 0.0022
618 LACRIMATION INCREASED 65 0.0021
619 DEAFNESS 56 0.0021
620 PRODUCT PREPARATION ISSUE 14 0.0021
621 DEVICE USE ERROR 74 0.0021
622 PHARYNGITIS STREPTOCOCCAL 23 0.0021
623 PAIN 1304 0.0021
624 CIRCULATORY COLLAPSE 36 0.0021
625 SCAB 24 0.0021
626 HYPOKALAEMIA 97 0.0021
627 PULMONARY MASS 31 0.0021
628 SUDDEN DEATH 22 0.0021
629 IRRITABLE BOWEL SYNDROME 44 0.0021
630 GASTROINTESTINAL INFLAMMATION 16 0.0020
631 ADVERSE DRUG REACTION 183 0.0020
632 TEMPERATURE INTOLERANCE 21 0.0020
633 BLOOD CREATININE INCREASED 132 0.0020
634 PHOTOPHOBIA 38 0.0020
635 DEFAECATION URGENCY 14 0.0020
636 INSOMNIA 529 0.0020
637 NEPHROLITHIASIS 91 0.0020
638 RENAL PAIN 21 0.0020
639 BRAIN FOG 31 0.0020
640 DISEASE PROGRESSION 234 0.0020
641 MULTIPLE ORGAN DYSFUNCTION SYNDROME 56 0.0020
642 GAIT DISTURBANCE 378 0.0020
643 HYPOACUSIS 85 0.0020
644 PYREXIA 683 0.0020
645 TOOTH INFECTION 26 0.0020
646 MUSCULAR WEAKNESS 224 0.0020
647 DIVERTICULUM 14 0.0020
648 BALANCE DISORDER 170 0.0020
649 CARDIAC MURMUR 17 0.0020
650 SKIN INFECTION 22 0.0020
651 OCULAR DISCOMFORT 22 0.0020
652 INFLAMMATION 101 0.0020
653 PRODUCT USE ISSUE 367 0.0020
654 ULCER 31 0.0019
655 MITRAL VALVE INCOMPETENCE 22 0.0019
656 COVID-19 341 0.0019
657 GROIN PAIN 17 0.0019
658 PHARYNGITIS 24 0.0019
659 CHOLECYSTITIS 23 0.0019
660 APPENDICITIS 18 0.0019
661 LUNG INFILTRATION 17 0.0019
662 COAGULOPATHY 32 0.0019
663 ACUTE KIDNEY INJURY 292 0.0019
664 INFARCTION 13 0.0019
665 FOOT FRACTURE 36 0.0019
666 INCONTINENCE 20 0.0019
667 ARTHROPOD BITE 14 0.0019
668 DEVICE ISSUE 169 0.0019
669 FACIAL PARALYSIS 16 0.0019
670 EXTRA DOSE ADMINISTERED 76 0.0019
671 DYSURIA 69 0.0019
672 ROAD TRAFFIC ACCIDENT 78 0.0019
673 UNRESPONSIVE TO STIMULI 48 0.0019
674 CYSTITIS 59 0.0019
675 RETINAL DETACHMENT 17 0.0018
676 SHOCK HAEMORRHAGIC 15 0.0018
677 PNEUMONIA ASPIRATION 46 0.0018
678 MENORRHAGIA 36 0.0018
679 BLOOD GLUCOSE DECREASED 88 0.0018
680 VITREOUS FLOATERS 18 0.0018
681 CHOLELITHIASIS 60 0.0018
682 INFECTION 263 0.0018
683 PELVIC FRACTURE 14 0.0018
684 DEPRESSED MOOD 95 0.0018
685 MOOD ALTERED 49 0.0018
686 SPINAL PAIN 21 0.0018
687 SKIN DISCOLOURATION 82 0.0018
688 SHOCK 41 0.0018
689 DYSPHAGIA 169 0.0018
690 SOMNOLENCE 358 0.0018
691 BLOOD ALBUMIN DECREASED 14 0.0018
692 DRY MOUTH 143 0.0018
693 VISION BLURRED 241 0.0018
694 RASH PRURITIC 95 0.0018
695 HELICOBACTER INFECTION 18 0.0017
696 ANURIA 15 0.0017
697 FULL BLOOD COUNT DECREASED 35 0.0017
698 INTERSTITIAL LUNG DISEASE 84 0.0017
699 LOWER LIMB FRACTURE 33 0.0017
700 DYSSTASIA 50 0.0017
701 GLOMERULAR FILTRATION RATE DECREASED 21 0.0017
702 ABNORMAL FAECES 14 0.0017
703 PANIC ATTACK 62 0.0017
704 ANXIETY 482 0.0017
705 CYST 21 0.0017
706 AGEUSIA 42 0.0017
707 CARDIAC ARREST 139 0.0017
708 CEREBRAL HAEMORRHAGE 60 0.0017
709 ANGINA PECTORIS 48 0.0017
710 BONE PAIN 98 0.0017
711 HAEMODIALYSIS 14 0.0017
712 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 80 0.0017
713 BACK DISORDER 27 0.0017
714 MEMORY IMPAIRMENT 228 0.0017
715 APHONIA 23 0.0016
716 CARPAL TUNNEL SYNDROME 23 0.0016
717 HIP ARTHROPLASTY 25 0.0016
718 DEVICE MALFUNCTION 114 0.0016
719 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 292 0.0016
720 NEPHROPATHY 15 0.0016
721 MIDDLE INSOMNIA 30 0.0016
722 CARDIO-RESPIRATORY ARREST 67 0.0016
723 ARTHRITIS 126 0.0016
724 MICTURITION URGENCY 18 0.0016
725 EMBOLISM 13 0.0016
726 WOUND INFECTION 17 0.0016
727 TOOTH FRACTURE 17 0.0015
728 WOUND 43 0.0015
729 LIVER FUNCTION TEST INCREASED 33 0.0015
730 TREMOR 255 0.0015
731 TENDERNESS 16 0.0015
732 NEUROPATHY PERIPHERAL 146 0.0015
733 MENTAL IMPAIRMENT 37 0.0015
734 PSEUDOMONAS INFECTION 13 0.0015
735 HERPES ZOSTER 87 0.0015
736 VENTRICULAR TACHYCARDIA 25 0.0015
737 INABILITY TO AFFORD MEDICATION 15 0.0015
738 MACULAR DEGENERATION 18 0.0015
739 PNEUMONITIS 41 0.0015
740 ABDOMINAL PAIN LOWER 38 0.0015
741 VAGINAL HAEMORRHAGE 65 0.0015
742 INTENTIONAL PRODUCT USE ISSUE 131 0.0015
743 INJECTION SITE IRRITATION 19 0.0015
744 OSTEOMYELITIS 27 0.0015
745 MOBILITY DECREASED 107 0.0015
746 PRODUCT ADMINISTRATION ERROR 30 0.0015
747 THROAT TIGHTNESS 40 0.0015
748 COLITIS 56 0.0015
749 SPEECH DISORDER 76 0.0014
750 ACCIDENTAL OVERDOSE 53 0.0014
751 PRODUCT DOSE OMISSION IN ERROR 41 0.0014
752 EYE DISCHARGE 15 0.0014
753 ERYTHEMA 296 0.0014
754 AUTOIMMUNE DISORDER 14 0.0014
755 OCULAR HYPERAEMIA 68 0.0014
756 CATARACT 85 0.0014
757 KNEE OPERATION 14 0.0014
758 HYPOAESTHESIA 213 0.0014
759 MUSCLE ATROPHY 18 0.0014
760 ACUTE RESPIRATORY DISTRESS SYNDROME 25 0.0014
761 DISORIENTATION 56 0.0014
762 BURNING SENSATION 99 0.0014
763 BLADDER DISORDER 14 0.0014
764 HAEMORRHAGE INTRACRANIAL 21 0.0014
765 THIRST 25 0.0014
766 TACHYPNOEA 19 0.0014
767 HEPATIC ENCEPHALOPATHY 13 0.0014
768 DYSGEUSIA 103 0.0014
769 LEUKAEMIA 13 0.0014
770 JOINT STIFFNESS 36 0.0014
771 BLOOD BILIRUBIN INCREASED 37 0.0014
772 ORAL CANDIDIASIS 18 0.0014
773 LUNG NEOPLASM MALIGNANT 56 0.0014
774 HEPATIC FAILURE 41 0.0014
775 ADVERSE REACTION 18 0.0014
776 URINARY INCONTINENCE 40 0.0013
777 DISCOMFORT 82 0.0013
778 PETECHIAE 14 0.0013
779 QUALITY OF LIFE DECREASED 18 0.0013
780 BRONCHOSPASM 19 0.0013
781 URINARY RETENTION 44 0.0013
782 NOCTURIA 16 0.0013
783 CONFUSIONAL STATE 212 0.0013
784 INCREASED APPETITE 25 0.0013
785 HYPERTENSION 277 0.0013
786 RESPIRATORY ARREST 36 0.0013
787 ENCEPHALOPATHY 32 0.0013
788 OVARIAN CYST 13 0.0013
789 SPINAL FRACTURE 26 0.0013
790 ORAL DISCOMFORT 18 0.0013
791 ORAL PAIN 29 0.0013
792 SLEEP DISORDER 91 0.0013
793 HYPERHIDROSIS 166 0.0013
794 DEVICE BREAKAGE 52 0.0013
795 PROCEDURAL PAIN 35 0.0013
796 HEPATIC FUNCTION ABNORMAL 47 0.0013
797 OBSTRUCTIVE AIRWAYS DISORDER 14 0.0013
798 LOWER RESPIRATORY TRACT INFECTION 57 0.0013
799 EYE DISORDER 41 0.0012
800 BLOOD CALCIUM DECREASED 14 0.0012
801 VISUAL IMPAIRMENT 154 0.0012
802 EYE INFECTION 14 0.0012
803 DEVICE ADHESION ISSUE 19 0.0012
804 BURSITIS 15 0.0012
805 NO THERAPEUTIC RESPONSE 15 0.0012
806 BLOOD PRESSURE INCREASED 188 0.0012
807 WHITE BLOOD CELL COUNT INCREASED 47 0.0012
808 EYE PRURITUS 41 0.0012
809 BREAST PAIN 13 0.0012
810 MASS 17 0.0012
811 SKIN HAEMORRHAGE 18 0.0012
812 CONTRAINDICATED PRODUCT ADMINISTERED 36 0.0012
813 LYMPHADENOPATHY 42 0.0012
814 THINKING ABNORMAL 22 0.0012
815 INSURANCE ISSUE 18 0.0012
816 RASH GENERALISED 30 0.0012
817 PRURITUS GENERALISED 25 0.0012
818 NEOPLASM MALIGNANT 77 0.0012
819 NODULE 15 0.0011
820 FUNGAL INFECTION 38 0.0011
821 KNEE ARTHROPLASTY 24 0.0011
822 IMMUNE SYSTEM DISORDER 15 0.0011
823 PANCREATITIS 60 0.0011
824 HYPOAESTHESIA ORAL 17 0.0011
825 PARAESTHESIA 176 0.0011
826 EYELID OEDEMA 13 0.0011
827 HAEMATURIA 38 0.0011
828 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19 0.0011
829 INCORRECT DOSE ADMINISTERED 251 0.0011
830 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
831 EJECTION FRACTION DECREASED 17 0.0011
832 LOCAL SWELLING 19 0.0011
833 ILL-DEFINED DISORDER 66 0.0011
834 PLATELET COUNT INCREASED 14 0.0011
835 DEMENTIA 30 0.0011
836 FIBROMYALGIA 26 0.0011
837 TRANSIENT ISCHAEMIC ATTACK 36 0.0011
838 PRURITUS 407 0.0011
839 CHRONIC KIDNEY DISEASE 80 0.0011
840 SKIN IRRITATION 48 0.0010
841 END STAGE RENAL DISEASE 19 0.0010
842 RASH 453 0.0010
843 TOOTH DISORDER 23 0.0010
844 BODY TEMPERATURE INCREASED 21 0.0010
845 DEVICE USE ISSUE 18 0.0010
846 HYPERSENSITIVITY 191 0.0010
847 RASH ERYTHEMATOUS 49 0.0010
848 BRADYCARDIA 54 0.0010
849 ASPARTATE AMINOTRANSFERASE INCREASED 54 0.0010
850 BLISTER 57 0.0010
851 BLOOD ALKALINE PHOSPHATASE INCREASED 25 0.0010
852 DEPRESSION 223 0.0010
853 SEIZURE 113 0.0010
854 CHROMATURIA 22 0.0010
855 RASH MACULAR 34 0.0010
856 INJECTION SITE WARMTH 20 0.0010
857 HYPERKALAEMIA 34 0.0010
858 FEMUR FRACTURE 30 0.0010
859 APHASIA 29 0.0010
860 MUSCULOSKELETAL DISORDER 18 0.0009
861 CARDIOVASCULAR DISORDER 24 0.0009
862 UNDERDOSE 69 0.0009
863 HYPONATRAEMIA 52 0.0009
864 PHOTOSENSITIVITY REACTION 15 0.0009
865 CRYING 33 0.0009
866 HYPOGLYCAEMIA 44 0.0009
867 EYE PAIN 51 0.0009
868 DYSARTHRIA 34 0.0009
869 PARAESTHESIA ORAL 13 0.0009
870 HYPOKINESIA 13 0.0009
871 PRODUCT USE COMPLAINT 14 0.0009
872 INJECTION SITE ERYTHEMA 110 0.0009
873 ALANINE AMINOTRANSFERASE INCREASED 54 0.0009
874 OBESITY 14 0.0009
875 SKIN DISORDER 29 0.0009
876 ASTHMA 98 0.0009
877 PANCYTOPENIA 48 0.0009
878 FRACTURE 16 0.0008
879 MUSCULOSKELETAL STIFFNESS 74 0.0008
880 LIP SWELLING 28 0.0008
881 APPLICATION SITE PRURITUS 19 0.0008
882 DEEP VEIN THROMBOSIS 54 0.0008
883 AMNESIA 54 0.0008
884 INTENTIONAL PRODUCT MISUSE 72 0.0008
885 ORAL HERPES 16 0.0008
886 ACUTE MYOCARDIAL INFARCTION 24 0.0008
887 BLOOD GLUCOSE ABNORMAL 15 0.0008
888 DERMATITIS 17 0.0008
889 HEPATIC STEATOSIS 15 0.0008
890 RASH PAPULAR 18 0.0008
891 COMA 38 0.0008
892 METASTASES TO LIVER 14 0.0008
893 DIABETES MELLITUS 60 0.0008
894 OFF LABEL USE 687 0.0008
895 INJECTION SITE RASH 24 0.0008
896 GLAUCOMA 15 0.0008
897 NIGHT SWEATS 25 0.0008
898 DIPLOPIA 20 0.0008
899 RESTLESSNESS 28 0.0008
900 DYSKINESIA 31 0.0008
901 HYPOTHYROIDISM 24 0.0008
902 DELIRIUM 26 0.0007
903 INJECTION SITE PRURITUS 50 0.0007
904 URTICARIA 125 0.0007
905 INJECTION SITE HAEMORRHAGE 59 0.0007
906 DRUG ERUPTION 13 0.0007
907 OSTEOARTHRITIS 31 0.0007
908 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
909 THROMBOCYTOPENIA 80 0.0007
910 IRRITABILITY 43 0.0007
911 DISABILITY 14 0.0007
912 SWOLLEN TONGUE 22 0.0007
913 HALLUCINATION 53 0.0007
914 WHITE BLOOD CELL COUNT DECREASED 76 0.0007
915 MUSCLE TWITCHING 16 0.0007
916 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
917 CEREBROVASCULAR ACCIDENT 117 0.0007
918 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 49 0.0007
919 ABASIA 17 0.0007
920 EMOTIONAL DISORDER 21 0.0007
921 INJECTION SITE SWELLING 52 0.0007
922 MYOCARDIAL INFARCTION 117 0.0007
923 PAIN OF SKIN 18 0.0007
924 MENTAL DISORDER 29 0.0007
925 BLINDNESS 27 0.0007
926 ALOPECIA 130 0.0007
927 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 47 0.0007
928 METABOLIC ACIDOSIS 21 0.0007
929 LIVER INJURY 16 0.0007
930 DISTURBANCE IN ATTENTION 35 0.0006
931 PRODUCT PHYSICAL ISSUE 13 0.0006
932 THERAPEUTIC RESPONSE DECREASED 39 0.0006
933 PLASMA CELL MYELOMA 25 0.0006
934 CORONARY ARTERY DISEASE 19 0.0006
935 HEPATIC CANCER 15 0.0006
936 DRY SKIN 83 0.0006
937 LIVER FUNCTION TEST ABNORMAL 18 0.0006
938 DRUG INTERACTION 98 0.0006
939 ARTHROPATHY 34 0.0006
940 NERVOUS SYSTEM DISORDER 19 0.0006
941 INJECTION SITE PAIN 183 0.0006
942 JAUNDICE 16 0.0006
943 GASTRIC CANCER 15 0.0006
944 APPLICATION SITE PAIN 13 0.0006
945 AGITATION 43 0.0006
946 NEEDLE ISSUE 17 0.0006
947 OSTEOPOROSIS 24 0.0006
948 SKIN LESION 16 0.0006
949 APPLICATION SITE ERYTHEMA 15 0.0006
950 DEVICE DIFFICULT TO USE 37 0.0006
951 C-REACTIVE PROTEIN INCREASED 20 0.0005
952 HEPATIC ENZYME INCREASED 37 0.0005
953 ANGIOEDEMA 24 0.0005
954 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 109 0.0005
955 VISUAL ACUITY REDUCED 17 0.0005
956 INJURY 34 0.0005
957 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
958 BLOOD GLUCOSE INCREASED 90 0.0005
959 RENAL INJURY 14 0.0005
960 INCORRECT DRUG ADMINISTRATION DURATION 13 0.0005
961 RHEUMATOID ARTHRITIS 52 0.0005
962 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 20 0.0004
963 PRODUCT USE IN UNAPPROVED INDICATION 106 0.0004
964 IMPAIRED HEALING 14 0.0004
965 BREAST CANCER 39 0.0004
966 DRUG-INDUCED LIVER INJURY 13 0.0004
967 HYPERGLYCAEMIA 15 0.0004
968 COLITIS ULCERATIVE 18 0.0004
969 ECZEMA 21 0.0004
970 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
971 SKIN EXFOLIATION 33 0.0004
972 EYE IRRITATION 22 0.0004
973 SKIN BURNING SENSATION 27 0.0004
974 COGNITIVE DISORDER 17 0.0004
975 DRY EYE 18 0.0004
976 MEDICATION ERROR 20 0.0004
977 NO ADVERSE EVENT 65 0.0004
978 DRUG INEFFECTIVE 471 0.0004
979 OVERDOSE 68 0.0003
980 MATERNAL EXPOSURE DURING PREGNANCY 27 0.0003
981 RENAL CANCER 13 0.0003
982 INJECTION SITE BRUISING 20 0.0003
983 ACNE 19 0.0003
984 ACCIDENTAL EXPOSURE TO PRODUCT 23 0.0002
985 BLADDER CANCER 13 0.0002
986 INJECTION SITE REACTION 15 0.0002
987 SUICIDAL IDEATION 18 0.0002
988 INFUSION RELATED REACTION 13 0.0002
989 PSORIASIS 25 0.0002
990 TREATMENT FAILURE 15 0.0002
991 TOXICITY TO VARIOUS AGENTS 19 0.0001
992 NEUTROPENIA 14 0.0001